Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alzheimer's Disease (AD): early-phase trial registry
4 of 7 indexed Alzheimer's Disease (AD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Alzheimer's Disease (AD): 7 US clinical trials tracked, 4 recruiting.
Alzheimer's Disease (AD) is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Molecular NeuroImaging, running 1 of these trials.
Enrollment posture brief
Registry condition alzheimers-disease-ad
OPEN 4 | RECR 57% | LATE 0 | EARLY 4 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Alzheimer's Disease (AD) lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alzheimer's Disease (AD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alzheimer's Disease (AD) is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Alzheimer's Disease (AD) trials is spread across many organizations.
Molecular NeuroImaging accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Alzheimer's Disease (AD) enrolment sits around 105 participants.
Median target enrolment is 105 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Alzheimer's Disease (AD) research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
UPenn Observational Research Repository on Neurodegenerative Disease
University of Pennsylvania
NCT04715399
δ in Dementia Clinical Trials
The University of Texas Health Science Center at San Antonio
NCT05592678
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Yale University
NCT06999434
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
University of California, Los Angeles
NCT06597942
Alzheimer's Disease Neuroimaging Initiative 2
University of Southern California
NCT01231971
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms
Mayo Clinic
NCT01780519
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Molecular NeuroImaging
NCT02103894
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Alzheimer's Disease (AD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alzheimer's Disease (AD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alzheimer's Disease (AD) page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Alzheimer's Disease (AD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Molecular NeuroImaging sponsors the most Alzheimer's Disease (AD) trials on record, review their full trial history before evaluating a specific study. See Molecular NeuroImaging's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alzheimer's Disease (AD) condition card totals 7 registered trials; most-linked intervention [18F]T807 ([18f]mni-777); top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.